Overview

Curcumin Biomarker Trial in Head and Neck Cancer

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
There is considerable evidence that turmeric consumption may have a protective effect against cancer progression. The purpose of this study is to examine the short-term effects of supplementation with a turmeric extract, Curcumin C3 Complex®, on biomarkers of head and neck squamous cell carcinoma (HNSCC).
Phase:
Early Phase 1
Details
Lead Sponsor:
Louisiana State University Health Sciences Center Shreveport
Collaborators:
Feist-Weiller Cancer Center at Louisiana State University Health Sciences
National Cancer Institute (NCI)
Treatments:
Curcumin